24 results
PRE 14A
QNCX
Quince Therapeutics Inc
4 Apr 23
Preliminary proxy
4:33pm
is intended to provide a total compensation package that enables us to attract and retain qualified and experienced individuals to serve as directors
8-K
EX-2.1
4w2mubj1d2lu rvur7c
12 May 22
Entry into a Material Definitive Agreement
5:12pm
DEF 14A
n3fm 9wxqg
22 Apr 20
Definitive proxy
3:26pm
10-K
g0dirw5cdo bk9ly
16 Mar 20
Annual report
4:16pm
10-Q
h3s10xltnsxgdf64jj
12 Jun 19
Quarterly report
4:19pm
424B4
j55946
9 May 19
Prospectus supplement with pricing info
5:14pm